• +1 240 760 2512
  • info@kammerman.com



5 November 2019

The Loulou Foundation invites Dr. Kammerman to speak at the 2019 CDKL5 Forum

Invited speaker and biostatistics regulatory consultant

CDKL5 Forum Annual Meeting

Cambridge, Massachusetts, USA

Access Dr. Kammerman’s presentation, “How to design clinical studies for small populations

11 September 2019

Dr. Kammerman appointed to “External Technical Advisory Committee", Northwestern University Clinical Outcomes Assessment Team (NUCOAT)

Regulatory statistics and COA consultant

NUCOAT, led by David Cella Ph.D., M.A., at Northwestern University, will develop core physical function outcome sets that measure the full range of physical function severity with potential generalizability across conditions.  NUCOAT was awarded a CDER Pilot Grant to foster the development of publicly available core sets of COAs.

08 April 2019

2019 DIA/FDA Biostatistics Industry and Regulator Forum

01 February 2019

DIA names Dr. Kammerman an Associate Editor of Therapeutic Innovation & Regulatory Science (TIRS) Journal

Associate Editor

Therapeutic Innovation & Regulatory Science (TIRS) Journal

17 October 2018

Longitudinal Modeling Approaches to Assess the Association Between Changes in 2 Clinical Outcome Assessments



STAT Virtual Journal Club of the Drug Information Association

2 October 2018

Advancing Endpoint Development for Preterm Neonates with Pulmonary Morbidities

Invited endpoints expert

Washington, DC

Duke-Margolis Center for Health Policy

21 September 2018

Advancing the Science of Study Endpoints: Endpoint Evolution During Drug Development – Time to Deterioration Endpoint Case Study

Invited speaker and panel discussant

North Bethesda, MD

Drug Information Association